US FDA Authorize Keytruda Regimen as First-line Treatment for Cervical Cancer

Healthcare

The US FDA has now approved a combination of the chemotherapy and pembrolizumab, with or without the bevacizumab, for certain who are suffering from the persistent, metastatic or recurrent cervical cancer disease. This approval will be applied to the women having tumors that express the PD-L1 along with a combined positive score (CPS) of one or more than one, as it has been indicated by a test authorized by FDA.

The US FDA has also converted it from the accelerated to the regular approval use of the pembrolizumab alone for such group of women have in the disease progression on or after the chemotherapy, and the accelerated approval of the test from the US FDA had been granted in the month of June 2018, along with a companion diagnostic.

Bradley Monk, medical director of the US Oncology Research Gynaecology Program said, the cervical cancer has been more commonly affecting the younger women and many women of color in the United States, and sadly, the women, who are diagnosed with the recurrent, persistent or metastatic cervical cancer are often having a low rate of survival.

See also  Johnson & Johnson Launches First Satellite Center for Global Health Discovery in Asia Pacific

Bradley Monk also said, there have been no first-line approvals from the US FDA for the women suffering from persistent, metastatic, or recurrent cervical caner in the last seven years, and he is now very excited for this new approval from the US FDA of a new combination treatment with Keytruda, that has been offering a new option for the treatment for all the inappropriate patients in the United States.

Sandy

Writing is a medium to express feelings and convey facts. A creative mind never rests in peace and this amazing platform gives me the freedom to write about what I like most.

I’ve been a writer/blogger for the last twelve years and have covered technology-related topics. However, I also have considerable years of experience in writing for various domains – Technology, Beauty, Fashion, Pharmaceutical, human psychology etc. Technology is my forte.

I’ve handled many interesting projects. Writing is my passion. As an author, I’ve learned a lot in my long journey of penning down my thoughts!

See also  Study: Consuming Processed Food Hurting Brain